rs558770240
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_020433.5(JPH2):āc.661T>Cā(p.Phe221Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0011 in 1,502,424 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020433.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00588 AC: 891AN: 151630Hom.: 10 Cov.: 32
GnomAD3 exomes AF: 0.000751 AC: 77AN: 102496Hom.: 0 AF XY: 0.000610 AC XY: 35AN XY: 57350
GnomAD4 exome AF: 0.000560 AC: 757AN: 1350686Hom.: 6 Cov.: 32 AF XY: 0.000461 AC XY: 307AN XY: 665360
GnomAD4 genome AF: 0.00587 AC: 890AN: 151738Hom.: 10 Cov.: 32 AF XY: 0.00609 AC XY: 452AN XY: 74168
ClinVar
Submissions by phenotype
not specified Benign:4
p.Phe221Leu in exon 2 of JPH2: This variant is not expected to have clinical sig nificance due to high population frequency. It has been identified in 4.82% (8/ 166) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://ex ac.broadinstitute.org; rs558770240). -
- -
- -
- -
Hypertrophic cardiomyopathy Uncertain:1Benign:1
- -
- -
not provided Benign:2
See Variant Classification Assertion Criteria. -
JPH2: BS1, BS2 -
Hypertrophic cardiomyopathy 17 Uncertain:1
- -
JPH2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at